UK markets closed

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
306.69-7.43 (-2.37%)
At close: 04:00PM EDT
310.00 +3.31 (+1.08%)
After hours: 07:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 81.12B
Enterprise value 122.04B
Trailing P/E 16.17
Forward P/E 15.04
PEG ratio (5-yr expected) 1.37
Price/sales (ttm)1.30
Price/book (mrq)N/A
Enterprise value/revenue 1.88
Enterprise value/EBITDA 9.59

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 37.99%
S&P500 52-week change 322.36%
52-week high 3335.83
52-week low 3215.96
50-day moving average 3320.18
200-day moving average 3278.92

Share statistics

Avg vol (3-month) 31.11M
Avg vol (10-day) 31.51M
Shares outstanding 5264.48M
Implied shares outstanding 6264.82M
Float 8193.83M
% held by insiders 127.22%
% held by institutions 164.94%
Shares short (15 Apr 2024) 42.64M
Short ratio (15 Apr 2024) 43.11
Short % of float (15 Apr 2024) 41.36%
Short % of shares outstanding (15 Apr 2024) 41.00%
Shares short (prior month 15 Mar 2024) 42.99M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 40.86%
Trailing annual dividend rate 32.46
Trailing annual dividend yield 30.78%
5-year average dividend yield 40.90
Payout ratio 412.65%
Dividend date 329 Mar 2024
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.20%
Operating margin (ttm)14.76%

Management effectiveness

Return on assets (ttm)11.12%
Return on equity (ttm)845.54%

Income statement

Revenue (ttm)66.72B
Revenue per share (ttm)247.86
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 12.87B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)18.98
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)1.28B
Total cash per share (mrq)4.79
Total debt (mrq)42.1B
Total debt/equity (mrq)3,315.20%
Current ratio (mrq)1.16
Book value per share (mrq)-6.03

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)3.69B